Clinical Trial

Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder

Study acronym: PAP-AUD
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this study is to determine if a single dose of psilocybin administered with motivational enhancement therapy (MET) can reduce heavy drinking in patients with an alcohol use disorder (AUD).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-08-09; most recent amendment 2024-05-06.
Status change: Not Yet Recruiting → Recruiting 2024-03-22
Trial Details
NCT Number NCT05995769
Lead Sponsor University of Calgary
Collaborators: Johns Hopkins University, University of Maryland, Canadian Institutes of Health Research (CIHR)
Conditions Alcohol Use Disorder, Alcoholism
Enrollment 128 participants
Start Date 2024-03-20
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-07